A A A

The Global Cell Therapy Industry

By Project team , on 1 June 2014

Background

The BRITS tool incorporates data the BRITS team collected on cell therapy firms and R&D projects from a range of data sources that include the Citeline Pharmaprojects database, Recombinant Capital, LexisNexis, and Bloomberg. These data were used as input for the tool’s estimates of project risks and development times based on information provided by users about individual projects. The data, the BRITS team collected provides useful input across the following areas: